FIELD: chemistry.
SUBSTANCE: crystalline calcium salt of gluconic acid or its compound with excipients is processed in grinding activator devices, or to a value of supplied specific energy of not more than 10.4 kJ/g and achieving amorphous-crystalline state, or to a value of specific energy of not less than 10.5 kJ/g and achieving amorphous state. The obtained substances are analysed using X-ray diffraction, infrared, NMR, EPR spectroscopy, mass- and chromatography-mass spectrometry and differential thermal analysis.
EFFECT: mechano-activated amorphous and amorphous-crystalline compounds and compositions are used as active compounds for making pharmaceutical preparations.
13 cl, 10 dwg, 12 ex
Title | Year | Author | Number |
---|---|---|---|
CALCIUM GLUCONATE NANOSUBSTANCE OINTMENT FOR TREATING SKIN DISEASES RELATED TO CALCIUM DEFICIENCY | 2012 |
|
RU2506071C1 |
CALCIUM GLUCONATE NANOSUBSTANCE SUPPOSITORIES FOR TREATING DISEASES RELATED TO CALCIUM DEFICIENCY (VERSIONS) | 2012 |
|
RU2511649C1 |
DENTAL PENCIL WITH CALCIUM GLUCONATE NANOSUBSTANCE FOR TREATING DISEASES RELATED TO CALCIUM DEFICIENCY | 2012 |
|
RU2533264C2 |
METHOD OF TREATING NEUROSIS | 2013 |
|
RU2582971C2 |
METHOD FOR TREATING HYPOCALCEMIA, OSTEOPOROSIS , FRACTURES | 2004 |
|
RU2268053C1 |
METHOD OF OBTAINING PREPARATION, WHICH CONTAINS AMORPHOUS-CRYSTALLINE SALTS OF OROTIC ACID | 2013 |
|
RU2541806C1 |
AMORPHOUS ALLISARTAN ISOPROXIL, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING AMORPHOUS ALLISARTAN ISOPROXIL | 2014 |
|
RU2668267C2 |
AMORPHOUS CALCIUM CARBONATE, STABILIZED WITH POLYPHOSPHATES OR BISPHOSPHONATES | 2016 |
|
RU2739563C2 |
AMLODIPINE CAMSYLATE, METHOD FOR ITS PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2241701C1 |
PHARMACEUTICALLY ACCEPTABLE THYMODEPRESSIN SALTS AND METHOD OF OBTAINING THEREOF | 2007 |
|
RU2536685C2 |
Authors
Dates
2009-11-20—Published
2007-07-20—Filed